4/7/2017
FDA Allows Marketing of First Direct-to-Consumer Tests That Provide Genetic Risk Information for Certain Conditions, Including Celiac Disease
Celiac Disease Foundation welcomes the FDA announcement that 23andMe can offer accessible, lower-cost, direct-to-consumer genetic screening for a number of diseases, including celiac disease. Celiac disease is a serious, genetic, autoimmune disorder caused by an immune reaction to the ingestion of gluten. Although it is often thought of as a rare disease, researchers tell us…
Continue Reading